EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potency

Philip M Zakas, Sharon C Cunningham, Ann Doherty, Eva B van Dijk, Raed Ibraheim, Stephanie Yu, Befikadu D Mekonnen, Brendan Lang, Elizabeth J English, Gang Sun, Miles C Duncan, Matthew S Benczkowski und 22 weitere

Molecular Therapy · 2024

DOI: 10.1016/j.ymthe.2024.06.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Philip M Zakas und 33 weiteren Autor:innen. Beteiligte Einrichtung: Tessera Therapeutics, Inc., Somerville, MA 02143, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Hepatocytes, Transgenes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno-associated virus (rAAV) vector gene delivery systems have demonstrated great promise in clinical trials but continue to face durability and dose-related challenges. Unlike rAAV gene therapy, integrating gene addition approaches can provide curative expression in mitotically active cells and pediatric populations. We explored a novel in vivo delivery approach based on an engineered transposase, Sleeping Beauty (SB100X), delivered as an mRNA within a lipid nanoparticle (LNP), in combination with an rAAV-delivered transposable transgene. This combinatorial approach achieved correction of ornithine transcarbamylase deficiency in the neonatal Spfash mouse model following a single delivery to dividing hepatocytes in the newborn liver. Correction remained stable into adulthood, while a conventional rAAV approach resulted in a return to the disease state. In non-human primates, integration by transposition, mediated by this technology, improved gene expression 10-fold over conventional rAAV-mediated gene transfer while requiring 5-fold less vector. Additionally, integration site analysis confirmed a random profile while specifically targeting TA dinucleotides across the genome. Together, these findings demonstrate that transposable elements can improve rAAV-delivered therapies by lowering the vector dose requirement and associated toxicity while expanding target cell types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsHepatocytesTransgenesTransposasesNanoparticlesRNA, MessengerAnimalsMiceGenetic TherapyHumansGene ExpressionLipidsDisease Models, AnimalGene Transfer TechniquesOrnithine CarbamoyltransferaseLiposomes

Stichwörter der Autor:innen

Sleeping Beauty transposaseadeno-associated virus vectorgene additionlipid nanoparticlemRNA liver deliverymacaqueornithine transcarbamylasepartial hepatectomytransposition

Substanzen

TransposasesRNA, MessengerLipid NanoparticlesLipidssleeping beauty transposase, humanOrnithine CarbamoyltransferaseLiposomes

Autor:innen und Institutionen

  • Tessera Therapeutics, Inc., Somerville, MA 02143, USA.
  • Gene Therapy Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children's Hospitals Network, Westmead, NSW 2145, Australia.
  • Gene Therapy Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children's Hospitals Network, Westmead, NSW 2145, Australia; Discipline of Child and…
  • Tessera Therapeutics, Inc., Somerville, MA 02143, USA. Electronic address: wsalomon@tesseratx.com.

Zitieren

APA

Zakas, P. M., Cunningham, S. C., Doherty, A., van Dijk, E. B., Ibraheim, R., Yu, S., Mekonnen, B. D., Lang, B., English, E. J., Sun, G., Duncan, M. C., Benczkowski, M. S., Altshuler, R. C., Singh, M. J., Kibbler, E. S., Tonga, G. Y., Wang, Z. J., Wang, Z. J., Li, G., …, & Salomon, W. E. (2024). Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potency. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.06.021

Vancouver

Zakas PM, Cunningham SC, Doherty A, van Dijk EB, Ibraheim R, Yu S, et al. Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potency. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.06.021

BibTeX
@article{Zakas2024,
  author = {Zakas, Philip M and Cunningham, Sharon C and Doherty, Ann and van Dijk, Eva B and Ibraheim, Raed and Yu, Stephanie and Mekonnen, Befikadu D and Lang, Brendan and English, Elizabeth J and Sun, Gang and Duncan, Miles C and Benczkowski, Matthew S and Altshuler, Robert C and Singh, Malvenderjit Jagjit and Kibbler, Emily S and Tonga, Gulen Y and Wang, Zi Jun and Wang, Z Jane and Li, Guangde and An, Ding and Rottman, James B and Bhavsar, Yashvi and Purcell, Cormac and Jain, Rachit and Alberry, Ryan and Roquet, Nathaniel and Fu, Yanfang and Citorik, Robert J and Rubens, Jacob R and Holmes, Michael C and Cotta-Ramusino, Cecilia and Querbes, William and Alexander, Ian E and Salomon, William E},
  title = {Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potency},
  journal = {Molecular Therapy},
  year = {2024},
  doi = {10.1016/j.ymthe.2024.06.021}
}
Kostenlos starten →